Effect of N-Acetylcysteine and Fructose-1,6-Bisphosphate in the Treatment of Experimental Sepsis

Sepsis is a syndrome caused by uncontrolled systemic inflammatory response of the individual, which represents a serious epidemiological problem worldwide. The aim of this study was to investigate the effect of N-acetylcysteine (NAC) and fructose-1,6-bisphosphate (FBP) in the treatment of experiment...

Full description

Saved in:
Bibliographic Details
Published in:Inflammation Vol. 34; no. 6; pp. 539 - 550
Main Authors: de Mello, Ricardo Obalski, Lunardelli, Adroaldo, Caberlon, Eduardo, de Moraes, Cristina Machado Bragança, Christ Vianna Santos, Roberto, da Costa, Vinicius Lorini, da Silva, Gabriela Viegas, da Silva Scherer, Patrícia, Buaes, Luiz Eduardo Coimbra, da Silva Melo, Denizar Alberto, Donadio, Márcio Vinícius Fagundes, Nunes, Fernanda Bordignon, de Oliveira, Jarbas Rodrigues
Format: Journal Article
Language:English
Published: Boston Springer US 01-12-2011
Springer Nature B.V
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Sepsis is a syndrome caused by uncontrolled systemic inflammatory response of the individual, which represents a serious epidemiological problem worldwide. The aim of this study was to investigate the effect of N-acetylcysteine (NAC) and fructose-1,6-bisphosphate (FBP) in the treatment of experimental sepsis. We used rats that were divided into five experimental groups: normal control (not induced), septic control (induced using a capsule with non sterile fecal content and Escherichia coli ), treated with FBP (500 mg/kg i.p.), treated with NAC (150 mg/kg i.p.), and treated with the combination of FBP with NAC. In the group treated with NAC, 16.68% of the mice survived, the FBP reduced the mortality of mice during the acute stage of the disease and increased the animals’ survival time in 33.34%, and the combination of drugs had no effect. Our results show that NAC prevented the mortality of animals after septic induction. These data confirm the validity of the use of NAC in the treatment of sepsis. Our data also show that the synergistic action with FBP does not improve the picture.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0360-3997
1573-2576
DOI:10.1007/s10753-010-9261-9